Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 5Lymphoid 5Breast 3Thoracic 2Myeloid 2Gynecologic 2Genitourinary 2Dermatologic 2Classical hematology 2Plasma cell 1Other 1CNS 1

Conditions

Ovarian Neoplasms 586Uterine Cervical Neoplasms 497Endometrial Neoplasms 319Breast Neoplasms 140Uterine Cervical Dysplasia 103Neoplasms 102Carcinoma, Ovarian Epithelial 90Fallopian Tube Neoplasms 78Lung Neoplasms 65Colorectal Neoplasms 64Uterine Neoplasms 61Vulvar Neoplasms 56Pancreatic Neoplasms 56Papillomavirus Infections 53Prostatic Neoplasms 52Stomach Neoplasms 49Colonic Neoplasms 47Peritoneal Neoplasms 41Melanoma 39Urinary Bladder Neoplasms 37Carcinoma, Non-Small-Cell Lung 37Esophageal Neoplasms 36Head and Neck Neoplasms 32Pelvic Neoplasms 29Vaginal Neoplasms 28Recurrence 28Rectal Neoplasms 27Ovarian Cysts 27Endometrial Hyperplasia 26Sarcoma 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Autoimmune Diseases × Gynecologic × Clear all
NCT02253251 2025-01-23

Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

MiraKind

Recruiting
15,000 enrolled
BreastGynecologic

Autoimmune Diseases, Breast Neoplasms, Endometriosis, Neoplasms, Ovarian Neoplasms

NCT00340600 2020-11-16

Continuation of Follow-up of DES-Exposed Cohorts

National Institutes of Health Clinical Center (CC)

Completed
10,805 enrolled
BreastGenitourinaryGynecologic

Autoimmune Diseases, Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡